<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD2961432">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo>
                        <nonSort>The </nonSort>
                        <title>Diminishment of Novel Endometrial Carcinoma-Derived Stem-like Cells by Targeting Mitochondrial Bioenergetics and MYC</title>
                    </titleInfo>
                    <name type="personal">
                        <namePart type="given">Laureen P.</namePart>
                        <namePart type="family">Helweg</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Beatrice Ariane</namePart>
                        <namePart type="family">Windmöller</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Leonie</namePart>
                        <namePart type="family">Burghardt</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Jonathan</namePart>
                        <namePart type="family">Storm</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Christine</namePart>
                        <namePart type="family">Förster</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Nils</namePart>
                        <namePart type="family">Wethkamp</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Ludwig</namePart>
                        <namePart type="family">Wilkens</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Barbara</namePart>
                        <namePart type="family">Kaltschmidt</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Constanze</namePart>
                        <namePart type="family">Banz-Jansen</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Christian</namePart>
                        <namePart type="family">Kaltschmidt</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf">2022</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">Cancer stem cells (CSCs) are a small subpopulation of tumor cells harboring properties that include self-renewal, multi-lineage differentiation, tumor reconstitution, drug resistance and invasiveness, making them key players in tumor relapse. In the present paper, we develop new CSC models and analyze the molecular pathways involved in survival to identify targets for the establishment of novel therapies. Endometrial carcinoma-derived stem-like cells (ECSCs) were isolated from carcinogenic gynecological tissue and analyzed regarding their expression of prominent CSC markers. Further, they were treated with the MYC-signaling inhibitor KJ-Pyr-9, chemotherapeutic agent carboplatin and type II diabetes medication metformin. ECSC populations express common CSC markers, such as Prominin-1 and CD44 antigen as well as epithelial-to-mesenchymal transition markers, Twist, Snail and Slug, and exhibit the ability to form free-floating spheres. The inhibition of MYC signaling and treatment with carboplatin as well as metformin significantly reduced the cell survival of ECSC-like cells. Further, treatment with metformin significantly decreased the mitochondrial membrane potential of ECSC-like cells, while the extracellular lactate concentration was increased. The established ECSC-like populations represent promising in vitro models to further study the contribution of ECSCs to endometrial carcinogenesis. Targeting MYC signaling as well as mitochondrial bioenergetics has shown promising results in the diminishment of ECSCs, although molecular signaling pathways need further investigations.</abstract>
                    <subject>
                        <topic>cancer stem cells</topic>
                        <topic>endometrial cancer</topic>
                        <topic>primary endometrial cancer stem cells</topic>
                        <topic>MYC</topic>
                        <topic>metformin</topic>
                        <topic>mitochondria</topic>
                        <topic>EMT</topic>
                    </subject>
                    <classification authority="ddc">570</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>International Journal of Molecular Sciences</title>
                        </titleInfo>
                        <part>
                            <detail type="volume">
                                <number>23</number>
                            </detail>
                            <detail type="issue">
                                <number>5</number>
                            </detail>
                        </part>
                    </relatedItem>
                    <identifier type="eIssn">1422-0067</identifier>
                    <identifier type="MEDLINE">35269569</identifier>
                    <identifier type="urn">urn:nbn:de:0070-pub-29614321</identifier>
                    <identifier type="doi">10.3390/ijms23052426</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</accessCondition>
                    <recordInfo>
                        <recordIdentifier>bielefeld_pub_2961432</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_bielefeld_pub_2961432">
                <mets:FLocat xlink:href="https://pub.uni-bielefeld.de/download/2961432/2961433/ijms-23-02426-v2.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="bielefeld_pub_2961432" DMDID="DMD2961432">
            <mets:fptr FILEID="FILE0_bielefeld_pub_2961432"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
